Headache.

Slides:



Advertisements
Similar presentations
Headache.
Advertisements

بسم الله الرحمن الرحيم Headache and facial pain Dr.Hayder Kadhum H. FICM NEUR. /Fellow Ship-Luvan university KUFA COLLEGE OF MEDICINE.
Headache: When to see a physician Morris Levin, MD Section of Neurology Dartmouth Medical School.
Appendix.
Migraine and Dizziness
Headache Guideline Cumbria
Headaches - In Primary Care Dr M Banerjee GP Registrar Tadworth.
 Migraine is a benign and recurring syndrome of headache, nausea and vomiting, and /or other neurological dysfunction.  Migraine, the most common cause.
HEADACHE 4 th year module. Introduction Headaches are very common – who hasn’t had one? We see a lot of patients with headache in the ED and the trick.
INTERNATIONAL CLASSIFICATION of HEADACHE DISORDERS 2nd edition (ICHD-II)
2008. Diagnostic criteria  At least 10 episodes fulfilling following criteria  Headache lasting 30 mins to 7 days  Has 2 at least 2 of the following.
INTERNATIONAL CLASSIFICATION of HEADACHE DISORDERS 3rd edition beta, ICHD-3beta Jes Olesen, Danish Headach Center, Dept of Neurology, Glostrup Hospital,
Department of Neurology, SJUH Acute headache Problems that can not wait until the post take ward round
Headaches Alan Chan, MD % prevalence Tension most common Cluster HA men > women All other types women > men International Headache Society (IHS)
Approach to Headaches AIMGP Seminar October 2004 Manaf Qahtani.
Study Group Laura Maidment.  Primary headaches 1) Migraine 2) Tension –type headaches 3) Cluster headaches 4) Other primary headaches  Secondary headaches.
International Classification of Headache Disorders, 2nd ed. ICHD-II & Chronic Migraine Diagnostic Criteria l Chronic migraine: headache (not.
دکترمحمدرضانجفی استاد مغزواعصاب
Headache & Facial Pain John F. Rothrock, M.D. Professor & Vice Chair, UAB Neurology.
Ehab Samara Fedaa Matanes. Pain concentrated on one side of the head A debilitating neurobiological headache disorder Affects 28 million people in the.
跳转到第一页 Headache Zheng Dongming. 跳转到第一页 n The most common symptom in clinic n the causes are myriad. 1.intracranial disease 2.extracranial disease 3.functional.
Anti-Migraine Drugs Brian Lich April 3 rd, Overview Migraines: What are they? Symptoms? Causes? Migraines: What are they? Symptoms? Causes? History:
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 30 Drugs for Headache.
Dr. amal Alkhotani Frcpc neurology, epilepsy
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
Diagnosis and management of primary headache
Headache.
Headache Dr. Mansour Al Moallem.
Neurology Lecture 4a Headaches.
Migraine Headaches Migraine Severe, throbbing, vascular headache
Dr David PB Watson GPwSI Headache Hamilton Medical Group Aberdeen
Czech headache guidelines for general practitioners Jolana Marková Thomayer University Hospital Prague.
Dr David PB Watson GPwSI Hamilton Medical Group Aberdeen
Migraine Headaches Migraine – Severe, throbbing, vascular headache – Recurrent unilateral head pain – Combined with neurologic and GI disturbances.
HEADACHES PBL STEVEN J. SCHEINER, M.D. Board Certified in Pain Medicine Board Certified in Neurology Diplomate, American Academy of Pain Management Senior.
Classification of Headache
 Headache is the 4th most common symptom of outpatient visits.
جامعة الكوفه مركز تطوير التدريس والتدريب الجامعي Tention Headache اعداد د. محمد راضي رديف بورد طب جمله عصبيه كلية الطب – جامعة الكوفه 2015 م.
Headache Dr.Ghayath. Headache account for up to 4% of medical office visits Headache is caused by traction, displacement, inflammation, vascular spasm,
Dublin November 13 th 2011 By Dr. Edward O’Sullivan 13-Nov
Headache. Learning objectives Gain organised knowledge in the subject area of headache Be able to take a headache history Know and apply the relevant.
Approach to the Patient with Head and Facial Pain Neurology
Headache Headache affects 75% of population per year (45 million people) and 25% of Neurology OP referrals Daily headache affects 4% of population On.
원더스 참고자료 두통. 1 차성 두통에 대한 자료 2 차성 두통에 대한 자료.
Approach to patient with Headache. Introduction pain cranium faceneck Headache.
Headache Clare Galton Consultant Neurologist 14/1/15.
MANAGAMENT OF MIGRAINE. Migraine Facts Migraine is one of the common causes of recurrent headaches Migraine is one of the common causes of recurrent headaches.
Headache. Migraine Migraine is an episodic primary headache disorder. Symptoms typically last 4 to 72 h and may be severe. Pain is often unilateral, throbbing,
Dr. Margaret Gluszynski
Approach to patient with headache
Dr. Saad Al Asiri FACIAL PAIN & HEADACHE MD, DLO, KSF, Rhino
Drugs for Headaches 1.
Headache.
Dr. Margaret Gluszynski
Headache.
Headache Dr shinisha paul.
Andrew Graham Consultant Neurologist June
Migraine Headaches Migraine Severe, throbbing, vascular headache
Headaches Feedback from BASH 3rd Nov 2017.
Dr Mohamad Shehadeh Agha MD MRCP(UK)
Headache (HA) JHL Module
Headache.
Headache is a common presenting complaint and certainly something you’ll encounter many times over your career. The vast majority of headaches are not.
Prof. Abdelmoniem Sahal Elmardi
INTERNATIONAL CLASSIFICATION of HEADACHE DISORDERS 3rd edition beta, ICHD-3beta Jes Olesen, Danish Headach Center, Dept of Neurology, Glostrup Hospital,
INTERNATIONAL CLASSIFICATION of HEADACHE DISORDERS 3rd edition beta, ICHD-3beta Jes Olesen, Danish Headach Center, Dept of Neurology, Glostrup Hospital,
Approach to Headache Dr. Dua’a Hiasat. Family Medicine Specialist.
Dr sadik al ghazawi Associated professer Neurologist Mrcp,frcp uk
Dr sadik al ghazawi Associated professer Neurologist Mrcp,frcp uk
Tension Type Headache Cluster headache
Presentation transcript:

Headache

Headache Diagnosis is based on  history Classification - IHS (International headache society) – 1988 3rd Edition – ICHD3 - 2017

Headache - classification Part I - Primary headaches Migraine Tension-type headache Trigeminal autonomic cephalalgias Other primary headache disorders

Headache - classification Part II - The secondary headaches Headache attributed to trauma or injury to the head and neck Headache attributed to cranial or cervical vascular disorders Headache attributed to non-vascular intracranial disorder Headache attributed o substance or its withdrawal Headache attributed to infection Headache attributed to disorder of homeostasis

Headache - classification Part II - The secondary headaches Headache or facial pain attributed to disorder of the cranium, neck, eyes, ears, nose, sinuses, teeth, mouth, or other facial or cervical structure Headache attributed to psychiatric disorder Part III – Painful cranial neuropathies, other facial pains and other headaches Painful cranial neuropathies and facial pains Other headache disorder

Migraine Migraine without aura Migraine with aura Chronic migraine Complications of migraine Probable migraine Episodic syndromes that may be associated with migraine

Tension type headache Infrequent episodic tension-type headache Chronic tension-type headache Probable episodic tension-type headache

Trigeminal autonomic cephalalgias (TACs) Cluster headache Paroxysmal hemicrania Short-lasting unilateral neuralgiform headache attacks (SUNCT) Hemicrania continua Probable trigeminal autonomic cephalalgia

Other primary headaches Primary stabbing headache Primary cough headache Primary exertonial headache Primary headache associated with sexual activity Hypnic headache Primary tunderclap headache Hemicrania continua New daily-persistent headache

Headache quality intensity localisation response on the physical characteristics quality     intensity  localisation response on the physical activity accompanying signs      Haas, D.C., SUNY Upstate Medical University, 2002

Headache Accompanying signs nauzea, vomitus phonophoby, photophoby aura informations about drugs which are used

Migraine prevalence – 10% prevalence in women Nauzea 17,5 % Fonofóbia prevalence in men 5,7 % positive familial history 58 %              Nauzea  Fonofóbia Fotofóbia Bolesť Unilaterálna Pulzujúca Provokovaná fyzickou aktivitou              Haas, D.C., SUNY Upstate Medical University, 2002

Pathophysiology of migraine Hypotalamus and limbic system prodroms Neuronal dysfunction and vascular changes aura and headache

Pathophysiology of migraine Spreading depression of CBF from occipital region during aura Spreading depression activate trigeminovascular endings

Pathophysiology of migraine It is unknown mechanism of activation nuclei in brainstem (nc. caudalis trigeminalis) - by spreading depression - by biochemical chnages - both Activation stimulate perifepheral findings of n.V.

Pathophysiology of migraine After stimulation of n. V. - production of P substance P and neurokinin A  neurogenic inflammation Stimulation of serotoninergic cells

Pathophysiology of migraine Receptors of 5-HT: activation of inhibiting 5-HT1B/1D receptores  production of serotonin, P substance, neurokinin  block of neurogenic inflammation agonists of these receptores – treatment of migraine (DH-ergotamín, triptans)

Pathophysiology of migraine The neuropeptide calcitonin gene-related peptide (CGRP) play an integral role in the pathophysiology of migraine. It is a potent peptide vasodilatator

Migraine Nauzea Phonophoby Photophoby Pain Unilateral Pulsating Provoke by physical activity Lasts 4 – 72 hodín              Haas, D.C., SUNY Upstate Medical University, 2002

Factors provoke atack of migraine Hormonal (menstruation, kontraceptives) Dietetical (alcohol, Na glutamat, chocolate, cheese) Psychological (stress, anxieta, depression) From environment (odors, changes of weather, high above sea-level) Drugs ( NTG, histamin, reserpin, estrogens) Others (head injury, physical activity)

Migraine without aura D. During headache ≥1 of the folloving A. At least 5 atacks fulfilling criteria B-D B. Headache attacks lasting 4-72 hours C. Headache has ≥ of the folloving characteristics Unilateral location Pulsating quality Moderate or severe pain intensity Aggravation by úhysical activity D. During headache ≥1 of the folloving Nausea or vomiting Photoúphobia or phonophobia E. Not better accounted for by another ICH3 diagnosis

Migraine with aura A. At least 2 atacks fulfilling criteria B and C B. ≥ 1of the folloving fully reversible aura symptoms 1. visual, 2. sensory, 3. speech and or llanguage, 4. motor, 5. brainstem, 6. retinal C. ≥ 2 of the folloving 2 characteristics ≥1 aura symptoms preads gradually over ≥ 5 min., and /or ≥ 2 symptoms occur in succession Each individual aura symptom lasts 5-60 min. ≥ 1 aura symptom is unilateral Aura accompanied or followed in < 60 min. by headache D. Not better accounted for by another ICH3 diagnosis and TIA excluded

Migraine with aura Aura - visual - sensoric - afasic - motoric IHS – lasts: 4 – 60 min. (70% do 30´)

Migraine with aura Visual aura scintilating scotoma small point is enlarging to cik-cak border (scintilation), in the middle is dark scotoma Haas, D.C., SUNY Upstate Medical University, 2002

Migraine with aura Visual aura colloured scintilating scotoma Haas, D.C., SUNY Upstate Medical University, 2002

Migraine with aura Positive fenomenons cik-cak Negativ scotoms Haas, D.C., SUNY Upstate Medical University, 2002)

1.6. Compliations of migraine 1.6.1. Status migrenosus headache lasts more than72 hours 1.6.2. brain infarct neurological deficit is not reversible till 7 days and/or infarct on CT or others

Basilar migraine Headache Symptoms from brainstem double vision, NY, tinnitus, dysphonia, dysphagia, desorientation, quadruparesthesia, quadruparesis,

Auxiliary examination Radiological Different headache Daily headache Headache + neurological signs Headache not responding on treatment Posttraumatic headache

Auxiliary examinations Radiological To exclude brain tumor for patient CT-native , with contrast medium MRI, MR angiography, angiography

Auxilliary examinations Elektroencephalography X-ray of skull injury, TU X-ray of cervical spinal column

Auxilliary examinations Duplex ultrasound of carotid arteries, Transkranial Doppler Optic fundus  GLAUCOMA

Migraine - therapy Triptans (eletriptan, naratriptan, rizatriptan, sumatriptan, zolmitriptan) – middle or severe attacks of headache ASA Paracetamol + ASA + coffein Ibuprofen Naproxen DHE sc, im, iv

Migraine - therapy Triptany dose max.d. Sumatriptan 25-50-100 mg 300 Zolmitriptan 2,5 – 5 mg 10 Naratriptan 2,5 mg 5 Rizatriptan 5 – 10 mg 30 Eletriptan 40 - 80 mg 160

Migraine – therapy mechanism of triptans Vasoconstriction of meningeal, cerebral, pial vessels activation 5-HT1B receptores in smooth muscles of vessels Inhibition of neurogenic inflamation stimulation 5-HT1D receptores at the endings of trigeminal C and A fibers (subst. P, neurokinín A, CGRP) Central inhibition of pain activation 5-HT1D, 1F receptores in brainstem decrease excitability of neurones ncl. trig. caudalis

Migraine – New treatment Calcitonin gene-related peptide (CGRP) plays a crucial role in the pathogenesis of migraine. Monoclonal antibodies against CGRP and CGRP receptors for the treatment of migraine were recently developed Erenumab is a fully human monoclonal antibody developed to block the pathway of calcitonin gene-related peptide (CGRP).

Migraine – therapy Prevention – more than 3 attacks/month betablockers, blockers of calcium, chanels, valproid acid pizotifen

Tension headache The most often chronic headache Prevalence - women – 88% Prevalence – men – 69%  the most days outside of work

Tension headache Pain - around the head - nonpulsating - bilateral - 30 min. – 7 days - not increased by physical activity Haas, D.C., SUNY Upstate Medical University, 2002

Tension headache Increased muscle tone in the neck Stright cervical lordosis Therapy Analgetics, myorelaxants, nonsteroid antiflogistics, physioteraphy, psychoteraphy, local 1% mesocain

Cluster headache 6 times more frequent in men Pain - periorbital - frontal, temporal - UNILATERAL - burning Haas, D.C., SUNY Upstate Medical University, 2002

Cluster headache Pain Alarm-clock pain lasts: 15 – 180 min. shorter than migraine Congestion Lacrimation Conjuctival inflamation Therapy O2, triptans, DHE Alarm-clock pain -beginning at night

Chronic paroxysmal hemicrania More often in women Pain – unilateral - lasting: 2 – 45 min. - more times during the day - ipsilateral lacrimation, conjuctival inflammation - nasal congescion, rhinorea - ptosis Effect of Indometacin – dg. test

Nauzea, phono-, photophoby YES No Pain Migraine Tensiion headache Cluster headache Localisation Unilateral Bilateral Lasting 4 – 72 hours Hours - days 30 – 180 min Intensity Light - severe Light - middle Severe Nauzea, phono-, photophoby YES (could be) No Lacrimation, nasal congestion It could be

Subarachnoid haemorrhage Sudden onset of the strong headache Immediatelly to hospital  HOSPITAL

Trigeminal neuralgia Etiology – focal demyelinisation of n.V. or of ganglion Idiopatic – pulsations of arteries near n.V. Symptomatic – tumors Prevalence – 6/100000,more women, and older people

Trigeminal neuralgy Clinical feature shooting pain in area of n.V., increasing after chawing, in symptomatic - trigger area, loose of weight Therapy anticonvulsants – Gabapentin, alcoholisation of ganglion, surgery

Temporal arteriitis Inflammation of a. temporalis superficialis Age – risc factor Headache in temporal region, thick, painful temporal superficial artery, chawing claudications, stronger pain polymyalgia reumatica – spasm and pain of masticatory muscles

Temporal arteriitis Late diagnosis– risc of blindness and stroke Dg. – laboratory – FW, CRP, AG, biopsy Therapy – Prednison – 60 (100) mg/day long time, after decreasing – control of FW,  FW – back to former dose

Conclusion Headache – one of the most often symptoms Correct differential diagnosis  correct therapy  shortened headache  improving quality of life  economical profit, shortened working inability